Vilin Bio Med Limited (NSE:VILINBIO)
India flag India · Delayed Price · Currency is INR
28.90
+1.35 (4.90%)
Jan 23, 2026, 3:21 PM IST

Vilin Bio Med Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212020
Period Ending
Jan '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
403285265---
Upgrade
Market Cap Growth
59.23%7.37%----
Upgrade
Enterprise Value
407297255---
Upgrade
Last Close Price
28.9020.4019.00---
Upgrade
PE Ratio
160.76127.33163.21---
Upgrade
PS Ratio
2.021.921.68---
Upgrade
PB Ratio
1.741.231.16---
Upgrade
P/TBV Ratio
1.741.231.16---
Upgrade
P/OCF Ratio
-130.84----
Upgrade
EV/Sales Ratio
2.042.001.61---
Upgrade
EV/EBITDA Ratio
57.9937.7031.22---
Upgrade
EV/EBIT Ratio
68.1343.4737.14---
Upgrade
Debt / Equity Ratio
0.020.110.300.460.720.75
Upgrade
Debt / EBITDA Ratio
0.653.278.361.906.886.41
Upgrade
Debt / FCF Ratio
----25.39-
Upgrade
Asset Turnover
0.690.490.630.790.820.84
Upgrade
Inventory Turnover
3.653.044.884.594.134.33
Upgrade
Quick Ratio
3.331.391.260.871.631.58
Upgrade
Current Ratio
7.782.752.011.242.222.19
Upgrade
Return on Equity (ROE)
1.09%0.97%0.97%13.78%0.46%1.66%
Upgrade
Return on Assets (ROA)
1.28%1.42%1.71%9.72%2.51%2.70%
Upgrade
Return on Invested Capital (ROIC)
1.84%2.03%2.53%12.03%3.25%3.70%
Upgrade
Return on Capital Employed (ROCE)
2.60%2.90%3.00%21.70%6.70%7.20%
Upgrade
Earnings Yield
0.62%0.78%0.61%---
Upgrade
FCF Yield
-4.35%-4.77%-28.00%---
Upgrade
Buyback Yield / Dilution
-0.47%--40.20%-20.61%--
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.